Related Experiment Video
Updated: Nov 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hip pathologies in mucopolysaccharidosis type III
Sandra Rafaela Breyer1,2,3, Eik Vettorazzi4, Leonie Schmitz4
1Department of Pediatric Orthopedics, Children's Hospital Altona, Bleickenallee 38, 22763, Hamburg, Germany. sandra.r.breyer@gmail.com.
Background:
Mucopolysaccharidosis type III (MPS III) comprises a group of rare lysosomal storage diseases. Although musculoskeletal symptoms are less pronounced than in other MPS subtypes, pathologies of hip and spine have been reported in MPS III patients. The purpose of this study was to describe hip pathologies and influencing parameters in MPS III patients.
Methods:
A retrospective chart review was performed for 101 MPS III patients. Thirty-two patients met the inclusion criteria of enzymatically or genetically confirmed diagnosis and anteroposterior radiograph of the hips. Modified Ficat classification, Wiberg's center-edge angle, and Reimer's migration percentage were measured.
Results:
The mean age at data assessment was 11.0 years (SD 5.7). Osteonecrosis of the femoral head was observed in 17/32 patients. No statistically significant association was found between these changes and age, sex, or MPS III subtype. Patients with a severe phenotype showed significantly higher rates of osteonecrosis (14/17) than patients with an intermediate phenotype. Hip dysplasia was present in 9/32 patients and was significantly associated with osteonecrosis of the femoral head (p = 0.04).
Conclusions:
The present study demonstrates a high rate of hip pathologies in MPS III patients. Hip dysplasia and severe phenotype were significantly correlated with osteonecrosis of the femoral head. Therefore, radiographs of the hips are highly recommended in baseline and follow-up assessments of MPS III patients.
Trial Registration:
Retrospectively registered.
Insights
Mucopolysaccharidosis type III (MPS III) patients show high rates of hip pathologies, particularly osteonecrosis of the femoral head. Severe phenotypes and hip dysplasia significantly increase this risk, necessitating regular hip imaging.
Area of Science:
- Orthopedics
- Genetics
- Rare Diseases
Background:
- Mucopolysaccharidosis type III (MPS III) is a rare lysosomal storage disease.
- While less common than in other MPS types, hip and spine pathologies occur in MPS III.
- This study focuses on hip issues in MPS III patients.
Purpose of the Study:
- To characterize hip pathologies in MPS III patients.
- To identify factors influencing these hip conditions.
Main Methods:
- Retrospective review of 101 MPS III patients.
- Inclusion criteria: confirmed diagnosis and hip radiographs.
- Evaluated hip dysplasia and femoral head osteonecrosis using specific classifications.
Main Results:
- Osteonecrosis of the femoral head found in 17/32 patients.
- Hip dysplasia present in 9/32 patients, linked to osteonecrosis (p=0.04).
- Severe MPS III phenotype correlated with higher osteonecrosis rates.
Conclusions:
- MPS III patients exhibit a high prevalence of hip pathologies.
- Hip dysplasia and severe phenotype are risk factors for femoral head osteonecrosis.
- Routine hip radiography is recommended for MPS III patients.
Related Concept Videos
Lysosomal Hydrolases
Proteoglycans
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...

